4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Indivior Pharmaceuticals, Inc. (INDV) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in North Chesterfield, United States with about 827 employees. Its market capitalization is roughly $5 billion. In the fiscal year ended 2025-12-31, INDV reported $1.2B in revenue and $210M in net income.
Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
Interactive charts & full statements → Open the INDV valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $1.2B | $1.2B | $1.1B | $901M | — |
| Gross Profit | $993M | $957M | $919M | $750M | — |
| Operating Income (EBIT) | $265M | $234M | $247M | $215M | — |
| Net Income | $210M | $7M | ($126M) | ($44M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $317M | $358M | $314M | $302M | $266M | — |
| Gross Profit | $277M | $291M | $231M | $250M | $222M | — |
| Operating Income (EBIT) | $137M | $83M | $44M | $71M | $67M | — |
| Net Income | $89M | $102M | $42M | $18M | $47M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.2B | $1.3B | $1.8B | $1.8B | — |
| Total Liabilities | $1.3B | $1.7B | $2.0B | $1.7B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive INDV viewer.
About TickerBase · Data methodology & sources